Journal article
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial
- Abstract:
-
Background Chronic pelvic pain affects 2–24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in women with chronic pelvic pain and no obvious pelvic pathology.
Methods We performed a multicentre, randomised, double-blind, placebo-controlled randomised trial in 39 UK hospital centres. Eligible participants...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 398.4KB, Terms of use)
-
(Preview, Supplementary materials, Version of record, pdf, 199.0KB, Terms of use)
-
- Publisher copy:
- 10.1016/S0140-6736(20)31693-7
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet More from this journal
- Volume:
- 396
- Issue:
- 10255
- Pages:
- 909-917
- Publication date:
- 2020-09-24
- Acceptance date:
- 2020-07-21
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Language:
-
English
- Keywords:
- Pubs id:
-
1120758
- Local pid:
-
pubs:1120758
- Deposit date:
-
2020-07-23
- ARK identifier:
Terms of use
- Copyright holder:
- Horne et al.
- Copyright date:
- 2020
- Rights statement:
- Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record